title: The detrimental effect of anti-thyroid drugs on the outcome of radioiodine therapy is not directly due to decreased radioiodine uptake.
authors.forename: M A
authors.initials: MA
authors.lastname: Walter
authors.forename: M
authors.initials: M
authors.lastname: Christ-Crain
authors.forename: B
authors.initials: B
authors.lastname: Müller
authors.forename: J
authors.initials: J
authors.lastname: Müller-Brand
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D013956:Antithyroid Agents / Q000008:administration & dosage; D002231:Carbimazole / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant / Q000379:methods / Q000592:standards; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards*; D011836:Radiation Tolerance / Q000187:drug effects; D019275:Radiopharmaceuticals / Q000008:administration & dosage; D013971:Thyrotoxicosis / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy*; D017211:Treatment Failure; D016896:Treatment Outcome; D006113:United Kingdom
chemical_list: D013956:Antithyroid Agents; D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D002231:Carbimazole